Mukaltin 50 mg (30 tablets)

The instruction for medical use of Mukaltin® medicine the Trade name of Mukaltin® the International unlicensed name Is not present the Dosage form of the Tablet of 50 mg Structure One tablet contains active agent: mallow of medicinal extract of dry (Mucaltinum) of 50.00 mg, excipients: tartaric acid, Effer-Soda® 12, cellulose microcrystalline, calcium stearate. The description of the Tablet from cream till brown color with dark and light impregnations, a ploskotsilindrichesky form, with a facet. Pharmacotherapeutic group Drugs for elimination of symptoms of cold and cough. Expectorant drugs. The ATX R05CA code Pharmacological Mukaltin® properties represents mix of polysaccharides from a grass of a mallow medicinal, has expectorant properties. Thanks to reflex stimulation enhances activity of a ciliary epithelium and a vermicular movement of respiratory bronchioles in combination with strengthening of secretion of bronchial glands. Natrii hydrocarbonas dilutes a phlegm and increases bronchial secretion a little. Indications the Acute and chronic respiratory diseases which are followed by formation of the hardly separated phlegm of the increased viscosity: - obstructive bronchitis - a tracheobronchitis - a pneumoconiosis - a bronchoectatic disease - pneumonia - emphysema of lungs to Adults and children from 6 years to accept the Route of administration and doses on 1-2 tablets before meal 3-4 times a day. The course of treatment usually makes 7-14 days. Children can dissolve a drug tablet in 1/3 glasses of warm water. Side effects - allergic reaction in the form of skin rash, an itching - dyspepsia, Contraindication nausea - hypersensitivity to drug components - a peptic ulcer of a stomach and duodenum - Medicinal interactions of Mukaltin® it is possible to appoint children's age up to 6 years along with other drugs used at treatment of bronchopulmonary diseases. Мукалтин® it is not necessary to apply along with the drugs containing codeine and other antibechic medicines as it complicates expectoration of the diluted phlegm. The special instructions Pregnancy and the period of a lactation Use during pregnancy and a lactation is possible only when the expected advantage for mother exceeds potential risk for a fruit or the child. The feature of influence of drug on ability to run motor transport or potentially dangerous mechanisms does not influence. Overdose Symptoms: nausea, vomiting. Treatment: drug withdrawal, symptomatic therapy. A form of release and packing On 10 tablets in planimetric bezjyacheykovy packing from the paper combined four-layer or on 10 tablets in blister strip packaging from a film of polyvinylchloride / polivinildenkhloridny (PVH/PVDH) and aluminum foil. Planimetric bezjyacheykovy packings place in boxes of cardboard. On number of packs put the approved instructions for medical use in each box in the state and Russian languages. 3 blister strip packagings together with the approved instruction for medical use in the state and Russian languages place in a pack from cardboard. Packs with packings place in a box of cardboard. It is allowed blister strip packagings (without investment in a pack) together with the approved iinstruktion on medical use in the state and Russian languages to place in boxes of cardboard. It is allowed information from the approved instruction for medical use in the state and Russian languages to apply on packing. To Store storage conditions in the dry, protected from light place at a temperature not above 25 °C. To store out of children's reach! 2 years not to apply a period of storage after an expiration date. Prescription status Without prescription the Name and the country of the organization producer/packer of JSC Khimpharm, Republic of Kazakhstan, Shymkent, Rashidov St., 81 the Name and the country of the owner of the registration certificate of JSC Khimpharm, the Republic of Kazakhstan, Shymkent, st. Rashidova, 81 Name, the address and a contact information of the organization accepting in the territory of the Republic of Kazakhstan a claim (offer) from consumers on quality of products (goods): JSC Khimpharm, Republic of Kazakhstan, Shymkent, Rashidov St., 81 Phone number +7 7252 (610151) the E-mail address of complaints@santo.kz the Name, the address and a contact information of the organization in the territory of the Republic of Kazakhstan responsible for post-registration observation of safety of medicine of JSC Khimpharm, Republic of Kazakhstan, Shymkent, Rashidov St., 81